HBW Advisory Services’s AbbVie ABBV Stock Holding History

HBW Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Buy	7,190 +307	+4%	+$66K	0.16%	133
2026 Q1	$1.5M	Sell	6,883 -226	-3%	-$50.1K	0.16%	145
2025 Q4	$1.62M	Sell	7,109 -106	-1%	-$24.1K	0.18%	126
2025 Q3	$1.67M	Buy	7,215 +106	+1%	+$21.6K	0.19%	125
2025 Q2	$1.32M	Sell	7,109 -263	-4%	-$48.9K	0.16%	139
2025 Q1	$1.54M	Sell	7,372 -40	-0.5%	-$7.78K	0.22%	110
2024 Q4	$1.32M	Buy	7,412 +198	+3%	+$36.4K	0.14%	111
2024 Q3	$1.42M	Sell	7,214 -638	-8%	-$119K	0.21%	110
2024 Q2	$1.35M	Sell	7,852 -761	-9%	-$126K	0.22%	113
2024 Q1	$1.33M	Hold	8,613	–	–	0.25%	103
2023 Q4	$1.33M	Sell	8,613 -1,336	-13%	-$195K	0.25%	103
2023 Q3	$1.48M	Sell	9,949 -2,026	-17%	-$297K	0.31%	99
2023 Q2	$1.61M	Buy	11,975 +1,400	+13%	+$205K	0.35%	72
2023 Q1	$1.69M	Sell	10,575 -659	-6%	-$101K	0.42%	64
2022 Q4	$1.82M	Sell	11,234 -2,448	-18%	-$375K	0.48%	58
2022 Q3	$1.84M	Sell	13,682 -56	-0.4%	-$8.04K	0.51%	60
2022 Q2	$2.1M	Buy	13,738 +4,406	+47%	+$673K	0.54%	59
2022 Q1	$1.51M	Sell	9,332 -200	-2%	-$29.1K	0.53%	63
2021 Q4	$1.29M	Sell	9,532 -36,515	-79%	-$4.31M	0.3%	83
2021 Q3	$4.97M	Sell	46,047 -359	-0.8%	-$41K	1.28%	14
2021 Q2	$5.23M	Buy	46,406 +3,705	+9%	+$417K	1.37%	11
2021 Q1	$4.62M	Buy	42,701 +2,684	+7%	+$287K	1.23%	15
2020 Q4	$4.29M	Buy	40,017 +2,764	+7%	+$266K	1.3%	18
2020 Q3	$3.26M	Buy	37,253 +7,051	+23%	+$664K	1.34%	20
2020 Q2	$2.96M	Buy	30,202 +2,059	+7%	+$181K	1.38%	16
2020 Q1	$2.16M	Buy	28,143 +1,788	+7%	+$152K	1.56%	18
2019 Q4	$2.34M	Buy	26,355 +2,000	+8%	+$166K	1.36%	27
2019 Q3	$1.84M	Buy	+24,355	New	+$1.67M	1.76%	26

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HBW Advisory Services's ABBV Position: Q2 2026 in Review

HBW Advisory Services increased its AbbVie (ABBV) stake by 4.5% in Q2 2026, buying an estimated $66K and bringing the position to 7,190 shares worth $1.81M. The position accounts for 0.16% of the portfolio, ranked #133.

HBW Advisory Services first reported a position in ABBV in Q3 2019 and has held it in 28 quarters since. The position peaked at $5.23M in Q2 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

HBW Advisory Services held 7,190 shares of AbbVie worth $1.81M as of Q2 2026.
HBW Advisory Services bought 307 AbbVie shares in Q2 2026, an estimated $66K.
AbbVie made up 0.16% of HBW Advisory Services's portfolio in Q2 2026, its #133 holding.
HBW Advisory Services first reported a position in AbbVie in Q3 2019 and has held it in 28 quarters since.
HBW Advisory Services's AbbVie position peaked at $5.23M in Q2 2021.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.